Arrowstreet Capital’s Camden National CAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$540K Sell
11,377
-11,358
-50% -$532K ﹤0.01% 1657
2025
Q4
$986K Sell
22,735
-4,842
-18% -$195K ﹤0.01% 1552
2025
Q3
$1.06M Sell
27,577
-47,562
-63% -$1.91M ﹤0.01% 1586
2025
Q2
$3.05M Sell
75,139
-2,071
-3% -$81.2K ﹤0.01% 1327
2025
Q1
$3.12M Sell
77,210
-11,283
-13% -$487K ﹤0.01% 1168
2024
Q4
$3.78M Buy
88,493
+24,676
+39% +$1.09M ﹤0.01% 1086
2024
Q3
$2.64M Buy
+63,817
New +$2.42M ﹤0.01% 1161
2021
Q3
Sell
-5,906
Closed -$282K 1605
2021
Q2
$282K Sell
5,906
-14,449
-71% -$687K ﹤0.01% 1748
2021
Q1
$974K Buy
+20,355
New +$853K ﹤0.01% 1798
2020
Q2
Sell
-10,839
Closed -$341K 2303
2020
Q1
$341K Sell
10,839
-34,266
-76% -$1.44M ﹤0.01% 1613
2019
Q4
$2.08M Buy
45,105
+27,631
+158% +$1.22M ﹤0.01% 1129
2019
Q3
$757K Buy
17,474
+7,574
+77% +$329K ﹤0.01% 1233
2019
Q2
$454K Buy
+9,900
New +$433K ﹤0.01% 1201

Other funds holding CAC

Arrowstreet Capital's CAC Position: Q1 2026 in Review

Arrowstreet Capital reduced its Camden National (CAC) stake by 50% in Q1 2026, selling an estimated $532K and leaving 11,377 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Arrowstreet Capital first reported a position in CAC in Q2 2019 and has held it in 13 quarters since. The position peaked at $3.78M in Q4 2024. 175 funds tracked by Wall St. Rank hold CAC as of Q1 2026.

  • Arrowstreet Capital held 11,377 shares of Camden National worth $540K as of Q1 2026.
  • Arrowstreet Capital sold 11,358 Camden National shares in Q1 2026, an estimated $532K.
  • Camden National made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1657 holding.
  • Arrowstreet Capital first reported a position in Camden National in Q2 2019 and has held it in 13 quarters since.
  • Arrowstreet Capital's Camden National position peaked at $3.78M in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Camden National as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.